Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 0.3900
+0.0150 (4.00%)
Aug 26, 2026, 2:41 PM HKT
Immunotech Biopharm Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 61.75 | 54.46 | 46.96 | 52.16 | 58.45 | 353.34 |
Trading Asset Securities | - | 100.11 | 10.54 | 124.81 | 21.01 | - |
Cash & Short-Term Investments | 61.75 | 154.57 | 57.49 | 176.97 | 79.46 | 353.34 |
Cash Growth | 193.29% | 168.84% | -67.51% | 122.72% | -77.51% | -58.20% |
Other Receivables | 0.27 | - | 0.1 | - | - | - |
Receivables | 0.27 | - | 0.1 | - | - | - |
Inventory | 5.92 | 4.52 | 5.54 | 4.92 | 7.21 | 10.87 |
Other Current Assets | 5.47 | 12.51 | 24.36 | 32 | 31.44 | 47.99 |
Total Current Assets | 100.13 | 171.59 | 87.49 | 213.89 | 118.11 | 412.2 |
Property, Plant & Equipment | 358.98 | 407 | 451.6 | 500.76 | 527.25 | 426.59 |
Long-Term Investments | - | - | - | 46.36 | 140.18 | 163.18 |
Other Intangible Assets | 12.27 | 17.9 | 19.55 | 41.88 | 42.49 | 14.25 |
Long-Term Deferred Charges | 0.02 | 0.04 | 0.21 | 0.46 | 0.72 | 0.98 |
Other Long-Term Assets | 8.44 | 6.4 | 5.18 | 42.92 | 50.69 | 80.5 |
Total Assets | 479.84 | 602.94 | 564.04 | 846.28 | 879.44 | 1,098 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 33.95 | 35.23 | 33.61 | 46.76 | 37.39 | 32.15 |
Accrued Expenses | 21.68 | 26.45 | 21 | 21.65 | 27.17 | 22.24 |
Short-Term Debt | 0.21 | 0.21 | - | - | - | - |
Current Portion of Long-Term Debt | 301.4 | 336.61 | 268.1 | 326.84 | - | - |
Current Portion of Leases | 29.07 | 25.65 | 27.45 | 24.68 | 26.06 | 20.21 |
Current Income Taxes Payable | - | - | 0.96 | - | - | - |
Current Unearned Revenue | 0.99 | 1.37 | 1.78 | 1.85 | 4.36 | 5.19 |
Other Current Liabilities | 61.13 | 65.34 | 77.31 | 108.5 | 113.49 | 100.31 |
Total Current Liabilities | 448.42 | 490.85 | 430.21 | 530.28 | 208.47 | 180.1 |
Long-Term Debt | - | - | - | - | 1 | - |
Long-Term Leases | 71.45 | 77.79 | 89.02 | 105.66 | 122.75 | 90.85 |
Long-Term Unearned Revenue | 47.05 | 51.5 | 61.27 | 39.46 | 40.84 | 3.56 |
Total Liabilities | 566.91 | 620.14 | 580.5 | 675.39 | 373.07 | 274.51 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 4.31 | 4.31 | 3.58 | 3.58 | 3.58 | 3.58 |
Additional Paid-In Capital | - | 1,632 | 1,402 | 1,402 | 1,402 | 1,402 |
Retained Earnings | - | -2,036 | -1,805 | -1,618 | -1,283 | -965.22 |
Comprehensive Income & Other | -88.1 | 385.69 | 385.69 | 385.69 | 385.69 | 381.4 |
Total Common Equity | -83.79 | -13.93 | -13.3 | 173.62 | 508.44 | 822.26 |
Minority Interest | -3.28 | -3.28 | -3.16 | -2.73 | -2.07 | 0.92 |
Shareholders' Equity | -87.08 | -17.21 | -16.45 | 170.89 | 506.37 | 823.18 |
Total Liabilities & Equity | 479.84 | 602.94 | 564.04 | 846.28 | 879.44 | 1,098 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 402.12 | 440.26 | 384.56 | 457.17 | 149.81 | 111.05 |
Net Cash (Debt) | -340.38 | -285.7 | -327.07 | -280.2 | -70.35 | 242.29 |
Net Cash Growth | - | - | - | - | - | -69.50% |
Net Cash Per Share | -0.57 | -0.52 | -0.61 | -0.54 | -0.14 | 0.47 |
Filing Date Shares Outstanding | 617.5 | 617.5 | 514.58 | 514.58 | 514.58 | 514.58 |
Total Common Shares Outstanding | 617.5 | 617.5 | 514.58 | 514.58 | 514.58 | 514.58 |
Working Capital | -348.29 | -319.26 | -342.71 | -316.38 | -90.36 | 232.1 |
Book Value Per Share | -0.14 | -0.02 | -0.03 | 0.34 | 0.99 | 1.60 |
Tangible Book Value | -96.06 | -31.83 | -32.85 | 131.73 | 465.95 | 808.01 |
Tangible Book Value Per Share | -0.16 | -0.05 | -0.06 | 0.26 | 0.91 | 1.57 |
Land | - | 83.92 | 83.92 | 83.92 | 83.92 | 63.05 |
Machinery | - | 154.23 | 153.36 | 149.53 | 86.1 | 76.5 |
Construction In Progress | - | 113.47 | 113.42 | 107.65 | 208.53 | 151.85 |
Leasehold Improvements | - | 121.83 | 121.83 | 121.83 | 56.69 | 56.25 |